Xenon Pharmaceuticals Inc. (XENE): Shareholders' Equity
$581.76M
As of 2025-12-31
$1.24B
As of 2026-06-30
-6.9%
3-year compound annual growth
+27.7%
5-year compound annual growth
+25.3%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $581.76M | -22.9% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $754.90M | -18.6% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $927.92M | +28.6% | 2026-02-26, Balance as of period end |
| 2022-12-31 | $721.50M | +31.2% | 2025-02-27, Balance as of period end |
| 2021-12-31 | $550.03M | +221.0% | 2024-02-29, Balance as of period end |
| 2020-12-31 | $171.35M | +86.3% | 2023-03-01, Balance as of period end |
| 2019-12-31 | $91.98M | -11.0% | 2021-03-01, Balance as of period end |
| 2018-12-31 | $103.30M | +187.5% | 2020-03-09, Balance as of period end |
| 2017-12-31 | $35.93M | -43.8% | 2019-03-06, Balance as of period end |
| 2016-12-31 | $63.90M | +4.7% | 2018-03-07, Balance as of period end |
| 2015-12-31 | $61.03M | -16.1% | 2018-03-07, Balance as of period end |
| 2014-12-31 | $72.78M | n/m | 2017-03-08, Balance as of period end |
| 2013-12-31 | -$78.37M | n/m | 2016-03-08, Balance as of period end |
| 2012-12-31 | -$89.86M | n/a | 2015-03-12, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Xenon Pharmaceuticals Inc. (XENE) | 2025-12-31 | $581.76M | -22.9% |
| Adagene Inc. (ADAG) | 2025-12-31 | $35.35M | -30.0% |
| Bolt Biotherapeutics, Inc. (BOLT) | 2025-12-31 | $26.50M | -53.7% |
| Ovid Therapeutics Inc. (OVID) | 2025-12-31 | $130.66M | +91.5% |
| Aclaris Therapeutics, Inc. (ACRS) | 2025-12-31 | $103.08M | -33.7% |
| Whitehawk Therapeutics, Inc. (WHWK) | 2025-12-31 | $136.31M | +159.7% |
| Coya Therapeutics, Inc. (COYA) | 2025-12-31 | $43.03M | +8.7% |
| Immunome Inc. (IMNM) | 2025-12-31 | $634.34M | +250.1% |
| Roivant Sciences Ltd. (ROIV) | 2026-03-31 | $4.53B | -3.4% |
Compare XENE, ADAG, BOLT, OVID side by side · Screen every company in Pharmaceutical Preparations ↗